As of 2024-12-11, the Fair Value of Erytech Pharma SA (ERYP.PA) is -0.21 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.50 EUR, the upside of Erytech Pharma SA is -142.62%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -53.80 | -0.23 | - | - | -27.01 | |
| YoY growth | 26.61% | 99.58% | - | - | 63.09% | |
| Market Cap (mil) | 13.37 |
| P/E | |
| Forward P/E | 43.27x |
| EPS | -0.01 |
| Avg earnings growth rate | 63.09% |
| TTM earnings | -0.23 |